J Bartek1,2, K Sjåvik3, F Ståhl1, H Kristiansson1, O Solheim4,5,6, S Gulati4,5, L M Sagberg4,5,6, P Förander1, A S Jakola4,7,8. 1. Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet and Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden. 2. Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. 3. Department of Neurosurgery, University Hospital of North Norway, Tromsø, Norway. 4. Department of Neurosurgery, St.Olav University Hospital, Trondheim, Norway. 5. Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. 6. Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy, St.Olav Hospital, Trondheim, Norway. 7. Department of Neurosurgery, Sahlgrenska Univerity Hospital, Gothenburg, Sweden. 8. Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden.
Abstract
OBJECTIVE: Chronic subdural hematoma (cSDH) is a prevalent condition often seen in the elderly, with surgery being the treatment of choice when symptomatic. So far, few have explored the surgical outcomes in patients 90 years or older. The aim of this study was to investigate outcome after cSDH surgery in nonagenarians (≥90 y/o group) compared to younger adult patients (<90 y/o group). MATERIALS: In a Scandinavian population-based cohort we conducted a retrospective review of 1,254 patients undergoing primary burr-hole procedures for cSDH between January 1, 2005 and December 31, 2010 at three neurosurgical centers. In a comparative analysis, the primary end-point was difference in hematoma recurrence rates between the ≥90 y/o and <90 y/o groups. The secondary end-points were differences in perioperative morbidity and mortality between groups. RESULTS: 75 patients were 90 years or older. There was no significant difference in recurrences resulting in reoperation between the age groups (10.7% vs 13.6%, P=.47). There was also no significant difference in overall complication rate (4.1% vs 8.1%, P=.21) or severe complications (1.4% vs 2.0%, P=.68). There were three (4.0%) perioperative deaths within 30 days in the ≥90 y/o group and 40 (3.4%) in the <90 y/o group (P=.78). CONCLUSION: Patients 90 years or older had similar rates of recurrence, perioperative morbidity and perioperative mortality as compared to younger patients. Age alone should not be a contraindication for surgery in patients with cSDH.
OBJECTIVE:Chronic subdural hematoma (cSDH) is a prevalent condition often seen in the elderly, with surgery being the treatment of choice when symptomatic. So far, few have explored the surgical outcomes in patients 90 years or older. The aim of this study was to investigate outcome after cSDH surgery in nonagenarians (≥90 y/o group) compared to younger adult patients (<90 y/o group). MATERIALS: In a Scandinavian population-based cohort we conducted a retrospective review of 1,254 patients undergoing primary burr-hole procedures for cSDH between January 1, 2005 and December 31, 2010 at three neurosurgical centers. In a comparative analysis, the primary end-point was difference in hematoma recurrence rates between the ≥90 y/o and <90 y/o groups. The secondary end-points were differences in perioperative morbidity and mortality between groups. RESULTS: 75 patients were 90 years or older. There was no significant difference in recurrences resulting in reoperation between the age groups (10.7% vs 13.6%, P=.47). There was also no significant difference in overall complication rate (4.1% vs 8.1%, P=.21) or severe complications (1.4% vs 2.0%, P=.68). There were three (4.0%) perioperative deaths within 30 days in the ≥90 y/o group and 40 (3.4%) in the <90 y/o group (P=.78). CONCLUSION:Patients 90 years or older had similar rates of recurrence, perioperative morbidity and perioperative mortality as compared to younger patients. Age alone should not be a contraindication for surgery in patients with cSDH.
Authors: Daniel J Stubbs; Benjamin M Davies; Tom Bashford; Alexis J Joannides; Peter J Hutchinson; David K Menon; Ari Ercole; Rowan M Burnstein Journal: BMJ Open Date: 2020-06-30 Impact factor: 2.692
Authors: Edward Christopher; Michael T C Poon; Laurence J Glancz; Peter J Hutchinson; Angelos G Kolias; Paul M Brennan Journal: Neurosurg Rev Date: 2018-04-21 Impact factor: 3.042
Authors: Minna Rauhala; Pauli Helén; Karri Seppä; Heini Huhtala; Grant L Iverson; Tero Niskakangas; Juha Öhman; Teemu M Luoto Journal: Acta Neurochir (Wien) Date: 2020-03-07 Impact factor: 2.216
Authors: Hyuk-Jin Oh; Youngbeom Seo; Yoon-Hee Choo; Young Il Kim; Kyung Hwan Kim; Sae Min Kwon; Min Ho Lee; Kyuha Chong Journal: J Korean Neurosurg Soc Date: 2021-11-04